S. Jiang

发表

Plasma membrane-associated proteins with the ability to partially inhibit perforin-mediated lysis.

J. D. Young, D. Ojcius, S. Muller, 1991, Immunology letters.

Postnatal pre‐ and postexposure passive immunization strategies: protection of neonatal macaques against oral simian–human immunodeficiency virus challenge

H. Katinger, D. Montefiori, L. Cavacini, 2002, Journal of medical primatology.

Peptides mimicking selected disulfide loops in HIV-1 gp120, other than V3, do not elicit virus-neutralizing antibodies.

S. Jiang, A. Neurath, N. Strick, 1991, AIDS research and human retroviruses.

Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients.

Shibo Jiang, S. Jiang, A. Neurath, 1999, Biologicals : journal of the International Association of Biological Standardization.

N36, a synthetic N-terminal heptad repeat domain of the HIV-1 envelope protein gp41, is an activator of human phagocytes.

S. Su, S. Jiang, B. Li, 2000, Clinical immunology.

Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1)--II. Synthetic peptides linked to HIV-1 carrier proteins gag and nef.

M. Kieny, S. Jiang, H. Kolbe, 1991, Molecular immunology.

A salt bridge between an N-terminal coiled coil of gp41 and an antiviral agent targeted to the gp41 core is important for anti-HIV-1 activity.

A. K. Debnath, S. Jiang, 2000, Biochemical and biophysical research communications.

Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1.

A. Debnath, S. Jiang, A. Neurath, 1994, Journal of medicinal chemistry.

Multifaceted consequences of anti-gp41 monoclonal antibody 2F5 binding to HIV type 1 virions.

S. Jiang, A. Neurath, N. Strick, 1995, AIDS research and human retroviruses.

Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.

S. Jiang, A. Neurath, N. Strick, 1993, AIDS research and human retroviruses.

Synthetic peptides and anti-peptide antibodies as probes to study interdomain interactions involved in virus assembly: the envelope of the human immunodeficiency virus (HIV-1).

S. Jiang, A. Neurath, N. Strick, 1992, Virology.

Fusion-Induced Apoptosis Contributes to Thymocyte Depletion by a Pathogenic Human Immunodeficiency Virus Type 1 Envelope in the Human Thymus

Shibo Jiang, L. Su, S. Jiang, 2006, Journal of Virology.

A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody.

A. Debnath, S. Jiang, K. Lin, 1999, Journal of virological methods.

Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41.

S. Jiang, A. Neurath, N. Strick, 1993, Biochemical and biophysical research communications.

Effect of amino acid replacements, additions and deletions on the antiviral activity of a peptide derived from the HIV-1 GP41 sequence.

S. Jiang, K. Lin, S. Jiang, 1995, Peptide research.

TCR repertoire of suppressor CD8+CD28- T cell populations.

S. Jiang, G. Pennesi, R. Ciubotariu, 1999, Human immunology.

Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.

A. Debnath, A. K. Debnath, S. Jiang, 2000, Biochemical and biophysical research communications.

Resistance of cytolytic lymphocytes to perforin-mediated killing. Lack of correlation with complement-associated homologous species restriction

J. D. Young, B. Perussia, C. Liu, 1988, The Journal of experimental medicine.

Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41 [published erratum appears in J Exp Med 1992 Feb 1;175(2):621]

S. Jiang, A. Neurath, K. Lin, 1991, The Journal of experimental medicine.

Cytoplasts from cytotoxic T lymphocytes are resistant to perforin-mediated lysis.

J. D. Young, D. Ojcius, S. Jiang, 1991, Molecular immunology.

Purification of a membrane-associated serine esterase from murine cytotoxic T lymphocytes by a single reverse-phase column.

J. D. Young, D. Ojcius, C. Hasselkus-Light, 1990, Protein expression and purification.

Resistance to the pore-forming protein of cytotoxic T cells: comparison of target cell membrane rigidity.

J. D. Young, D. Ojcius, S. Jiang, 1990, Molecular immunology.

Perforin binding to cells and lipid membranes determined by a simple competition assay.

J. D. Young, D. Ojcius, S. Jiang, 1990, Journal of immunological methods.

Differential susceptibility of type III erythrocytes of paroxysmal nocturnal hemoglobinuria to lysis mediated by complement and perforin.

J. D. Young, B. Perussia, S. Jiang, 1989, Biochemical and biophysical research communications.

The lymphocyte pore-forming protein perforin is associated with granules by a pH-dependent mechanism.

J. D. Young, C. Liu, S. Jiang, 1989, Immunology letters.

Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity

J. D. Young, C. Liu, A. Zychlinsky, 1989, The Journal of experimental medicine.

Anti-idiotypic antibodies derived against C8, C9 and perforin bind homologous restriction factor.

J. D. Young, C. Liu, S. Jiang, 1990, Journal of immunological methods.

Anti-Human Immunodeficiency Virus Type 1 Microbicide Cellulose Acetate 1,2-Benzenedicarboxylate in a Human In Vitro Model of Vaginal Inflammation

R. Fichorova, S. Jiang, A. Neurath, 2005, Antimicrobial Agents and Chemotherapy.

Identification and characterization of a membrane-bound cytotoxin of murine cytolytic lymphocytes that is related to tumor necrosis factor/cachectin.

J. D. Young, C. Liu, S. Jiang, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Structure-based identification of small molecule antiviral compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1.

A. Debnath, Shibo Jiang, S. Jiang, 1999, Journal of medicinal chemistry.

Antibody responses of chimpanzees immunized with synthetic peptides corresponding to full-length V3 hypervariable loops of HIV-1 envelope glycoproteins.

M. Kieny, E. Muchmore, S. Jiang, 1991, AIDS research and human retroviruses.

Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro.

S. Lederman, S. Jiang, G. Pennesi, 1998, Human immunology.

CD28 superagonist antibody treatment attenuated obliterative bronchiolitis in rat allo-orthotopic tracheal transplantation by preferentially expanding Foxp3-expressing regulatory T cells.

S. Jiang, H. Fan, H. Cao, 2012, Transplantation proceedings.

Separate metabolic pathways leading to DNA fragmentation and apoptotic chromatin condensation

J. D. Young, D. Ojcius, S. Jiang, 1994, The Journal of experimental medicine.

The radiation-sensitive costimulatory factors involved in B-cell-dependent T-cell activation by minor lymphocyte stimulating antigen.

S. Jiang, K. Chang, J. Fu, 1998, Journal of biomedical science.

T suppressor lymphocytes inhibit NF-kappa B-mediated transcription of CD86 gene in APC.

S. Lederman, S. Jiang, R. Cortesini, 1999, Journal of immunology.

Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.

S. Jiang, J. Wang, J. Tang, 2008, Transplantation proceedings.

Resistance of cytolytic lymphocytes to perforin-mediated killing. Inhibition of perforin binding activity by surface membrane proteins.

J. D. Young, D. Ojcius, S. Jiang, 1990, Journal of immunology.